Search Results

Kidney Transplantation in Lupus Nephritis: Can We Do Even Better?

• Authors : Goyal N; Tufts Medical Center, Boston, Massachusetts (N.G., D.E.W., A.S.L.).; Weiner DE

Subjects: Kidney Failure, Chronic* ; Kidney Transplantation* ; Lupus Nephritis*

• Source: Annals of internal medicine [Ann Intern Med] 2019 Feb 19; Vol. 170 (4), pp. 266-267. Date of Electronic Publication: 2019 Jan 22.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

Kidney Transplants in Patients With Lupus Nephritis.

Subjects: Kidney Transplantation*; Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*surgery ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*complications

• Source: Annals of internal medicine [Ann Intern Med] 2019 Feb 19; Vol. 170 (4). Date of Electronic Publication: 2019 Jan 22.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.

• Authors : Jorge A; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.J., Z.S.W., N.L., Y.Z., H.K.C.).; Wallace ZS

Subjects: Kidney Transplantation*; Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*surgery ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*complications

• Source: Annals of internal medicine [Ann Intern Med] 2019 Feb 19; Vol. 170 (4), pp. 240-247. Date of Electronic Publication: 2019 Jan 22.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.

• Authors : Liu Z; Zhang H; Liu Z

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Glucocorticoids/Glucocorticoids/Glucocorticoids/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

• Source: Annals of internal medicine [Ann Intern Med] 2015 Jan 06; Vol. 162 (1), pp. 18-26.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Glucocorticoids/Glucocorticoids/Glucocorticoids/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

• Source: Annals of internal medicine [Ann Intern Med] 2015 Jan 06; Vol. 162 (1), pp. I24.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

• Authors : Illei GG; Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 10 Center Drive, Building 10, Room 9S-205, Bethesda, MD 20892, USA. ; Austin HA

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*administration & dosage ; Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*administration & dosage ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage

• Source: Annals of internal medicine [Ann Intern Med] 2001 Aug 21; Vol. 135 (4), pp. 248-57.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

Long-term outcome in lupus nephritis.

• Authors : Spiera RF; Homel P; Spiera H

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

• Source: Annals of internal medicine [Ann Intern Med] 2002 Sep 17; Vol. 137 (6), pp. 545-6; author reply 545-6.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.

• Authors : Levey AS; Division of Nephrology, New England Medical Center Hospital, Boston, MA 02111.; Lan SP

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*prevention & control ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

• Source: Annals of internal medicine [Ann Intern Med] 1992 Jan 15; Vol. 116 (2), pp. 114-23.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis.

• Authors : Roubenoff R; Johns Hopkins Medical Institutions, Baltimore, Maryland.; Drew H

Subjects: Cimetidine*; Creatinine/Creatinine/Creatinine/*metabolism ; Glomerular Filtration Rate/Glomerular Filtration Rate/Glomerular Filtration Rate/*drug effects

• Source: Annals of internal medicine [Ann Intern Med] 1990 Oct 01; Vol. 113 (7), pp. 501-6.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

The treatment of lupus nephritis: revisiting Galen.

• Authors : Lewis EJ

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

• Source: Annals of internal medicine [Ann Intern Med] 2001 Aug 21; Vol. 135 (4), pp. 296-8.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details